Citalopram amplifies the influence of living conditions on mood in depressed patients enrolled in the STAR*D study
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Selective serotonin reuptake inhibitors (SSRIs), the most commonly prescribed antidepressant drugs, have a variable and incomplete efficacy. In order to better understand SSRI action, we explored the hypothesis that SSRIs do not affect mood per se but amplify the influence of the living conditions on mood. To this aim, we exploited the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) data set, selected a subpopulation of 591 patients with an overlapping clinical history and analyzed treatment outcome according to dosage −20 or 40 mg per day of citalopram. We found that sociodemographic characteristics affected treatment response in the same direction in the two dose groups, but these effects reached statistical significance only in the 40 mg per day dose group. In the latter, higher improvement rate was associated with having a working employment status (P=0.0219), longer education (P=0.0053), high income (P=0.01) or a private insurance (P=0.0031), and the higher remission rate was associated with having a working employment status (P=0.0326) or longer education (P=0.0484). Moreover, the magnitude of the effect of the sociodemographic characteristics on mood, measured as the percent of patients showing a positive outcome when exposed to favorable living conditions, was much greater—up to 37-fold—in the 40 compared to the 20 mg per day dose group. Overall, our results indicate that citalopram amplifies the influence of the living conditions on mood in a dose-dependent manner. These findings provide a potential explanation for the variable efficacy of SSRIs and might lead to the development of personalized strategies aimed at enhancing their efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Socioeconomic Status and Health: What We Know and What We Don't
ADLER, N. E., & OSTROVE, J. M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08101.x · Cited by 1,643
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
Depression and socio-economic risk factors: 7-year longitudinal population study
Lorant, V., Croux, C., Weich, S., Deliège, D., Mackenbach, J., & Ansseau, M. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.020040 · Cited by 496
Wiles, N., Thomas, L., Abel, A., Ridgway, N., Turner, N., Campbell, J., Garland, A., Hollinghurst, S., Jerrom, B., Kessler, D., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61552-9 · Cited by 340
Moderators of Treatment Outcomes: Clinical, Research, and Policy Importance
Kraemer, H. C., Frank, E., & Kupfer, D. J. (2006) · JAMA · doi:10.1001/jama.296.10.1286 · Cited by 310
Alboni, S., van Dijk, R. M., Poggini, S., Milior, G., Perrotta, M., Drenth, T., Brunello, N., Wolfer, D. P., Limatola, C., Amrein, I., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2015.142 · Cited by 207
Self-citationTreating minority patients with depression and anxiety: What does the evidence tell us?
Schraufnagel, T. J., Wagner, A. W., Miranda, J., & Roy-Byrne, P. P. (2006) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.07.002 · Cited by 205
Branchi, I. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.08.011 · Cited by 156
Self-citation
Research works printed but not linked: 16
- Branchi I, Santarelli S, Capoccia S, Poggini S, D'Andrea I, Cirulli F et al. Antidepressant treatment outcome depends on the quality of the living environment: a pre-clinical investigation in mice. PLoS ONE 2013; 8: e62226. · DOI · Paper page
- Alboni S, Poggini S, Garofalo S, Milior G, El Hajj H, Lecours C et al. Fluoxetine treatment affects the inflammatory response and microglial function according to the quality of the living environment. Brain Behav Immun 2016; 58: 261–271. · DOI · Paper page
- Bornstein SR, Schuppenies A, Wong ML, Licinio J . Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006; 11: 892–902. · DOI · Paper page
- Mastronardi C, Paz-Filho GJ, Valdez E, Maestre-Mesa J, Licinio J, Wong ML . Long-term body weight outcomes of antidepressant-environment interactions. Mol Psychiatry 2011; 16: 265–272. · DOI
- Downing RW, Rickels K . Predictors of response to amitriptyline and placebo in three outpatient treatment settings. J Nervous Ment Dis 1973; 156: 109–129. · DOI
- Keitner GI, Ryan CE, Miller IW, Norman WH . Recovery and major depression: factors associated with twelve-month outcome. Am J Psychiatry 1992; 149: 93–99. · DOI
- Perlis RH, Alpert J, Nierenberg AA, Mischoulon D, Yeung A, Rosenbaum JF et al. Clinical and sociodemographic predictors of response to augmentation, or dose increase among depressed outpatients resistant to fluoxetine 20 mg per day. Acta Psychiatr Scand 2003; 108: 432–438. · DOI
- Rickels K, Jenkins BW, Zamostien B, Raab E, Kanther M . Pharmacotherapy in neurotic depression. Differential population responses. J Nervous Ment Dis 1967; 145: 475–485. · doi:10.1097/00005053-196712000-00005
- Ronalds C, Creed F, Stone K, Webb S, Tomenson B . Outcome of anxiety and depressive disorders in primary care. Br J Psychiatry 1997; 171: 427–433. · DOI · Paper page
- Spillmann M, Borus JS, Davidson KG, Worthington JJ 3rd, Tedlow JR, Fava M . Sociodemographic predictors of response to antidepressant treatment. Int J Psychiatr Med 1997; 27: 129–136. · DOI
- Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin N Am 2003; 26: 457–494, x. · DOI · Paper page
- Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK et al. Income and attrition in the treatment of depression: a STAR*D report. Depress Anxiety 2009; 26: 622–633. · DOI · Paper page
- Schmidt CO, Kohlmann T . When to use the odds ratio or the relative risk? Int J Public Health 2008; 53: 165–167. · DOI · Paper page
- Jain FA, Hunter AM, Brooks JO 3rd, Leuchter AF . Predictive socioeconomic and clinical profiles of antidepressant response and remission. Depress Anxiety 2013; 30: 624–630. · DOI · Paper page
- Hahn B, Flood AB . No insurance, public insurance, and private insurance: do these options contribute to differences in general health? J Health Care Poor Underserved 1995; 6: 41–59. · doi:10.1353/hpu.2010.0333
- Belsky J . The differential susceptibility hypothesis: sensitivity to the environment for better and for worse. JAMA Pediatr 2016; 170: 321–322. · DOI
Cited by
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“…of neural and behavioural plasticity is well recognised (Belsky and Pluess, 2013; Boyce and Ellis, 2005), and in this context, the plasticity-mediating role of serotonin is becoming increasingly well appreciated (Alboni et al., 2017; Belsky et al., 2009; Branchi, 2011; Chiarotti et al., 2017).”
BackgroundInfluentialPsychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Watts, R., Branchi, I., & Kaelen, M. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118754710 · Cited by 657
Self-citationYeshurun, S., & Hannan, A. J. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0039-z · Cited by 121
Murphy, S. E., Capitão, L. P., Giles, S. L. C., Cowen, P. J., Stringaris, A., & Harmer, C. J. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00154-1 · Cited by 112
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94
“antidepressants increases sensitivity to the environment [103,104].”
Metadata
- Authors
- Chiarotti, F., Viglione, A., Giuliani, A., & Branchi, I.
- Venue
- Translational Psychiatry
- Published
- 2017-03-21
- Volume
- 7
- Issue
- 3
- Pages
- e1066-e1066
- ISSN
- 2158-3188 (ISSN-L)
- OpenAlex
- W2603032646
- Cited by
- 68
- References
- 10
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.